Evidence map›Paper›PMID 33513714›Full record

Trial reportMarine drugs2021

Limited Benefit of Marine Protein Hydrolysate on Physical Function and Strength in Older Adults: A Randomized Controlled Trial.

Linda Kornstad Nygård, Ingunn Mundal, Lisbeth Dahl, Jūratė Šaltytė Benth, Anne Marie Mork Rokstad

Open access · goldAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Marine drugs, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.6field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 6 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Linda Kornstad NygårdFaculty of Health Sciences and Social Care, Molde University College, P.O. Box 2110, 6402 Molde, Norway.ORCID 0000-0002-6317-5516
Ingunn MundalFaculty of Health Sciences and Social Care, Molde University College, P.O. Box 2110, 6402 Molde, Norway.ORCID 0000-0001-7716-7122
Lisbeth DahlInstitute of Marine Research (IMR), P.O. Box 1870 Nordnes, 5817 Bergen, Norway.ORCID 0000-0001-9453-9821
Jūratė Šaltytė BenthInstitute of Clinical Medicine, Campus Ahus, University of Oslo, P.O. Box 1171, Blindern, 0318 Oslo, Norway.
Anne Marie Mork RokstadFaculty of Health Sciences and Social Care, Molde University College, P.O. Box 2110, 6402 Molde, Norway.
Molde University College · NONorwegian Institute of Marine Research · NOUniversity of Oslo · NO

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Age-related muscle wasting can compromise functional abilities of the elderly. Protein intake stimulates muscle protein synthesis; however, ageing muscle is more resistant to stimuli. This double-blinded, randomized, controlled trial is one of the first registered studies to evaluate the effects of a supplement of marine protein hydrolysate (MPH) on measures of physical function and strength. Eighty-six older adults received nutritional supplements containing 3 g of MPH or a placebo for up to 12 months. Short Physical Performance Battery (SPPB), grip strength and gait speed were measured, and dietary intake was registered at baseline, 6 months, and 12 months. No difference was found between the intervention and control groups in mean change in SPPB (independent sample

Indexed as

Dietary SupplementsExerciseAgedAged, 80 and overDouble-Blind MethodFemaleFish Proteins, DietaryFollow-Up StudiesHumansMaleMuscle, SkeletalMuscle StrengthProtein HydrolysatesFish Proteins, DietaryProtein Hydrolysatesageingdietary assessmentfish proteinhealthy ageinghydrolysatephysical functionseafood intake

Identifiers

PMID33513714
PMCPMC7912527
OpenAlexW3124187901

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.